{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T06:12:11Z","timestamp":1791353531576,"version":"4.3.1"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T00:00:00Z","timestamp":1763769600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T00:00:00Z","timestamp":1763769600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Biochem Biophys"],"DOI":"10.1007\/s12013-025-01954-5","type":"journal-article","created":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T06:26:31Z","timestamp":1763792791000},"page":"479-492","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The Dual Nature of Oncostatin M: Context-Dependent Mediator of Immunity and Fibrosis"],"prefix":"10.1007","volume":"84","author":[{"given":"Satyajit","family":"Tripathy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,22]]},"reference":[{"issue":"4","key":"1954_CR1","first-page":"1075","volume":"7","author":"M Tanaka","year":"1988","unstructured":"Tanaka, M., & Miyajima, A. (1988). Oncostatin M: A growth regulator produced by differentiated T cells. EMBO Journal, 7(4), 1075\u20131082.","journal-title":"EMBO Journal"},{"issue":"5","key":"1954_CR2","doi-asserted-by":"publisher","first-page":"2431","DOI":"10.4049\/jimmunol.159.5.2431","volume":"159","author":"CD Richards","year":"1997","unstructured":"Richards, C. D., Brown, T. J., Shoyab, M., Baumann, H., & Gauldie, J. (1997). Regulation of signaling by suppressors of cytokine signaling (SOCS). Journal of Immunology, 159(5), 2431\u20132437.","journal-title":"Journal of Immunology"},{"issue":"3","key":"1954_CR3","first-page":"1626","volume":"162","author":"HM Hermanns","year":"1999","unstructured":"Hermanns, H. M., Radtke, S., Schaper, F., & Heinrich, P. C. (1999). Oncostatin M and its role in inflammation and fibrosis. Journal of Immunology, 162(3), 1626\u20131632.","journal-title":"Journal of Immunology"},{"issue":"3","key":"1954_CR4","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1165\/rcmb.2006-0270OC","volume":"36","author":"T Weng","year":"2007","unstructured":"Weng, T., Devine, H., Richter, J. R., et al. (2007). Oncostatin M induces mucin gene expression and goblet cell differentiation in airway epithelial cells. American Journal of Respiratory Cell and Molecular Biology, 36(3), 296\u2013304.","journal-title":"American Journal of Respiratory Cell and Molecular Biology"},{"issue":"2","key":"1954_CR5","first-page":"1146","volume":"275","author":"L Dumoutier","year":"2000","unstructured":"Dumoutier, L., Lejeune, D., Hor, S., Fickenscher, H., & Renauld, J. C. (2000). Cloning and characterization of a new IL-6-related cytokine. Journal of Biological Chemistry, 275(2), 1146\u20131154.","journal-title":"Journal of Biological Chemistry"},{"issue":"7","key":"1954_CR6","first-page":"4752","volume":"166","author":"A Grenier","year":"2001","unstructured":"Grenier, A., Combaret, N., Paugam, C., et al. (2001). Oncostatin M production by dendritic cells regulates epithelial cell function. Journal of Immunology, 166(7), 4752\u20134758.","journal-title":"Journal of Immunology"},{"issue":"4","key":"1954_CR7","first-page":"755","volume":"40","author":"C Simpson","year":"1997","unstructured":"Simpson, C., Yamamura, Y., Page, T. H., et al. (1997). Oncostatin M induces IL-6 and RANKL from synovial fibroblasts. Arthritis & Rheumatism, 40(4), 755\u2013765.","journal-title":"Arthritis & Rheumatism"},{"issue":"5","key":"1954_CR8","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1038\/nm.4307","volume":"23","author":"NR West","year":"2017","unstructured":"West, N. R., Hegazy, A. N., Owens, B. M. J., et al. (2017). Oncostatin M drives intestinal inflammation and predicts response to anti-TNF therapy in IBD. Nature Medicine, 23(5), 579\u2013589.","journal-title":"Nature Medicine"},{"issue":"5","key":"1954_CR9","doi-asserted-by":"publisher","first-page":"110732","DOI":"10.1016\/j.celrep.2022.110732","volume":"39","author":"JJ Araujo","year":"2022","unstructured":"Araujo, J. J., Gonzalez, V. D., Menendez, J. A., et al. (2022). Oncostatin M promotes cancer-associated fibroblast activation and reshapes the breast tumor microenvironment. Cell Reports, 39(5), 110732. https:\/\/doi.org\/10.1016\/j.celrep.2022.110732","journal-title":"Cell Reports"},{"issue":"51","key":"1954_CR10","doi-asserted-by":"publisher","first-page":"32635","DOI":"10.1074\/jbc.271.51.32635","volume":"271","author":"B Mosley","year":"1996","unstructured":"Mosley, B., De Imus, C., Friend, D., et al. (1996). Dual Oncostatin M (OSM) receptor-specificity of human OSM is mediated by distinct receptor binding epitopes. Journal of Biological Chemistry, 271(51), 32635\u201332643. https:\/\/doi.org\/10.1074\/jbc.271.51.32635","journal-title":"Journal of Biological Chemistry"},{"issue":"2","key":"1954_CR11","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1042\/bj3340297","volume":"334","author":"PC Heinrich","year":"1998","unstructured":"Heinrich, P. C., Behrmann, I., M\u00fcller-Newen, G., et al. (1998). Interleukin-6-type cytokine signalling through the gp130\/Jak\/STAT pathway. Biochemical Journal, 334(2), 297\u2013314. https:\/\/doi.org\/10.1042\/bj3340297","journal-title":"Biochemical Journal"},{"issue":"6","key":"1954_CR12","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1158\/0008-5472.CAN-17-2654","volume":"78","author":"YJ Kang","year":"2018","unstructured":"Kang, Y. J., Bang, B. R., Otsuka, M., et al. (2018). Regulation of Yap transcriptional activity in inflammation and cancer. Cancer Research, 78(6), 1293\u20131304. https:\/\/doi.org\/10.1158\/0008-5472.CAN-17-2654","journal-title":"Cancer Research"},{"issue":"6642","key":"1954_CR13","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/40330","volume":"388","author":"M Tanaka","year":"2002","unstructured":"Tanaka, M., Ishihara, K., Hori, T., et al. (2002). Cloning and characterization of a new receptor subunit for Oncostatin M. Nature, 388(6642), 30\u201335. https:\/\/doi.org\/10.1038\/40330","journal-title":"Nature"},{"issue":"5","key":"1954_CR14","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.cytogfr.2015.07.006","volume":"26","author":"HM Hermanns","year":"2015","unstructured":"Hermanns, H. M. (2015). Oncostatin M and interleukin-6: Cytokines with multiple functions and overlapping activities. Cytokine & Growth Factor Reviews, 26(5), 379\u2013389.","journal-title":"Cytokine & Growth Factor Reviews"},{"issue":"25","key":"1954_CR15","doi-asserted-by":"publisher","first-page":"3553","DOI":"10.1038\/onc.2016.507","volume":"36","author":"DJ Junk","year":"2017","unstructured":"Junk, D. J., Bryson, B. L., Smigiel, J. M., Parameswaran, N., et al. (2017). Oncostatin M promotes cancer cell plasticity through cooperative STAT3-SMAD3 signalling. Oncogene, 36(25), 3553\u20133564. https:\/\/doi.org\/10.1038\/onc.2016.507","journal-title":"Oncogene"},{"issue":"5","key":"1954_CR16","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.cytogfr.2015.07.003","volume":"26","author":"HM Hermanns","year":"2015","unstructured":"Hermanns, H. M. (2015). Oncostatin M and interleukin-31: Cytokines, receptors, signal transduction and physiology. Cytokine & Growth Factor Reviews, 26(5), 545\u2013558. https:\/\/doi.org\/10.1016\/j.cytogfr.2015.07.003","journal-title":"Cytokine & Growth Factor Reviews"},{"issue":"1","key":"1954_CR17","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.cytogfr.2009.11.003","volume":"21","author":"SI Grivennikov","year":"2010","unstructured":"Grivennikov, S. I., & Karin, M. (2010). Dangerous liaisons: STAT3 and NF-\u03baB collaboration and crosstalk in cancer. Cytokine & Growth Factor Reviews, 21(1), 11\u201319. https:\/\/doi.org\/10.1016\/j.cytogfr.2009.11.003","journal-title":"Cytokine & Growth Factor Reviews"},{"issue":"1","key":"1954_CR18","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s12974-021-02076-7","volume":"18","author":"HL Hsu","year":"2021","unstructured":"Hsu, H. L., Hsu, C. L., Cheng, C. F., et al. (2021). OSM-induced TNF-\u03b1 and NF-\u03baB signaling crosstalk regulates inflammation in glial cells. Journal of Neuroinflammation, 18(1), 44. https:\/\/doi.org\/10.1186\/s12974-021-02076-7","journal-title":"Journal of Neuroinflammation"},{"key":"1954_CR19","doi-asserted-by":"publisher","first-page":"1608612","DOI":"10.3389\/fendo.2025.1608612","volume":"16","author":"X Lv","year":"2025","unstructured":"Lv, X., & Ding, S. (2025). Unraveling the role of STAT3 in cancer cachexia: Pathogenic mechanisms and therapeutic opportunities. Frontiers in Endocrinology, 16, 1608612.","journal-title":"Frontiers in Endocrinology"},{"issue":"9","key":"1954_CR20","doi-asserted-by":"publisher","first-page":"6024","DOI":"10.4049\/jimmunol.180.9.6024","volume":"180","author":"RB Crittenden","year":"2008","unstructured":"Crittenden, R. B., Ju, W., Sano, Y., et al. (2008). STAT3 activation in response to Oncostatin M regulates fibroblast function and contributes to tissue remodeling. Journal of Immunology, 180(9), 6024\u20136031. https:\/\/doi.org\/10.4049\/jimmunol.180.9.6024","journal-title":"Journal of Immunology"},{"issue":"1","key":"1954_CR21","doi-asserted-by":"publisher","first-page":"228","DOI":"10.4240\/wjgs.v16.i1.228","volume":"16","author":"Y Yang","year":"2024","unstructured":"Yang, Y., Fu, K. Z., & Pan, G. (2024). Role of Oncostatin M in the prognosis of inflammatory bowel disease: A meta-analysis. World Journal of Gastrointestinal Surgery, 16(1), 228.","journal-title":"World Journal of Gastrointestinal Surgery"},{"issue":"10","key":"1954_CR22","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1038\/ni829","volume":"3","author":"R Lang","year":"2002","unstructured":"Lang, R., Patel, D., Morris, J. J., Rutschman, R. L., & Murray, P. J. (2002). Shaping gene expression in activated and resting primary macrophages by IL-10 and STAT3. Nature Immunology, 3(10), 943\u2013950. https:\/\/doi.org\/10.1038\/ni829","journal-title":"Nature Immunology"},{"issue":"6","key":"1954_CR23","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1038\/ni928","volume":"4","author":"H Yasukawa","year":"2003","unstructured":"Yasukawa, H., Ohishi, M., Mori, H., et al. (2003). IL-6 induces an anti-inflammatory response in the absence of SOCS3 in macrophages. Nature Immunology, 4(6), 551\u2013556. https:\/\/doi.org\/10.1038\/ni928","journal-title":"Nature Immunology"},{"issue":"8","key":"1954_CR24","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1084\/jem.20161448","volume":"214","author":"NR West","year":"2017","unstructured":"West, N. R., Owens, B. M., & Hegazy, A. N. (2017). The role of IL-6 family cytokines in epithelial biology and immunopathology. Journal of Experimental Medicine, 214(8), 1227\u20131241. https:\/\/doi.org\/10.1084\/jem.20161448","journal-title":"Journal of Experimental Medicine"},{"issue":"12","key":"1954_CR25","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1056\/NEJM200103223441207","volume":"344","author":"EH Choy","year":"2001","unstructured":"Choy, E. H., & Panayi, G. S. (2001). Cytokine pathways and joint inflammation in rheumatoid arthritis. New England Journal of Medicine, 344(12), 907\u2013916. https:\/\/doi.org\/10.1056\/NEJM200103223441207","journal-title":"New England Journal of Medicine"},{"issue":"12","key":"1954_CR26","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1136\/thoraxjnl-2014-205018","volume":"69","author":"JL Simpson","year":"2014","unstructured":"Simpson, J. L., Phipps, S., Baines, K. J., et al. (2014). Elevated expression of the IL-6 receptor in asthma and chronic obstructive pulmonary disease. Thorax, 69(12), 1113\u20131120. https:\/\/doi.org\/10.1136\/thoraxjnl-2014-205018","journal-title":"Thorax"},{"issue":"6","key":"1954_CR27","doi-asserted-by":"publisher","first-page":"3220","DOI":"10.4049\/jimmunol.157.8.3220","volume":"157","author":"K Takeda","year":"1996","unstructured":"Takeda, K., Kamanaka, M., Tanaka, T., Kishimoto, T., & Akira, S. (1996). Impaired IL-13\u2013mediated functions of eosinophils in STAT6-deficient mice. Journal of Immunology, 157(6), 3220\u20133222.","journal-title":"Journal of Immunology"},{"issue":"7","key":"1954_CR28","doi-asserted-by":"publisher","first-page":"3545","DOI":"10.4049\/jimmunol.167.7.3545","volume":"167","author":"L Dumoutier","year":"2001","unstructured":"Dumoutier, L., Leemans, C., Lejeune, D., Kotenko, S. V., & Renauld, J. C. (2001). Cutting edge: STAT activation by IL-19, IL-20, and mda-7 through IL-20 receptor complexes of two types. Journal of Immunology, 167(7), 3545\u20133549. https:\/\/doi.org\/10.4049\/jimmunol.167.7.3545","journal-title":"Journal of Immunology"},{"issue":"3","key":"1954_CR29","doi-asserted-by":"publisher","first-page":"L547","DOI":"10.1152\/ajplung.2001.280.3.L547","volume":"280","author":"V Modur","year":"2001","unstructured":"Modur, V., Feldhaus, M. J., Weyrich, A. S., et al. (2001). Oncostatin M is a Proinflammatory mediator in pulmonary fibrosis. American Journal of Physiology-Lung Cellular and Molecular Physiology, 280(3), L547\u2013L556. https:\/\/doi.org\/10.1152\/ajplung.2001.280.3.L547","journal-title":"American Journal of Physiology-Lung Cellular and Molecular Physiology"},{"issue":"3","key":"1954_CR30","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.pharmthera.2009.08.004","volume":"124","author":"JL Simpson","year":"2009","unstructured":"Simpson, J. L., Phipps, S., & Gibson, P. G. (2009). Inflammatory mechanisms and treatment of obstructive airway diseases with eosinophilic inflammation. Pharmacology & Therapeutics, 124(3), 333\u2013349. https:\/\/doi.org\/10.1016\/j.pharmthera.2009.08.004","journal-title":"Pharmacology & Therapeutics"},{"issue":"1","key":"1954_CR31","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1038\/s41598-022-05208-9","volume":"12","author":"A Guo","year":"2022","unstructured":"Guo, A., Ross, C., Chande, N., Gregor, J., Ponich, T., Khanna, R., Sey, M., Beaton, M., Yan, B., Kim, R. B., & Wilson, A. (2022). High Oncostatin M predicts lack of clinical remission for patients with inflammatory bowel disease on tumor necrosis factor \u03b1 antagonists. Scientific Reports, 12(1), 1185.","journal-title":"Scientific Reports"},{"issue":"5609","key":"1954_CR32","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1126\/science.1081479","volume":"299","author":"F Powrie","year":"2003","unstructured":"Powrie, F., & Maloy, K. J. (2003). Immunology. Regulating the regulators. Science, 299(5609), 1030\u20131031. https:\/\/doi.org\/10.1126\/science.1081479","journal-title":"Science"},{"issue":"3","key":"1954_CR33","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/j.cell.2019.06.029","volume":"178","author":"CS Smillie","year":"2019","unstructured":"Smillie, C. S., Biton, M., Ordovas-Montanes, J., et al. (2019). Intra- and inter-cellular rewiring of the human colon during ulcerative colitis. Cell, 178(3), 714\u2013730e22. https:\/\/doi.org\/10.1016\/j.cell.2019.06.029","journal-title":"Cell"},{"issue":"7583","key":"1954_CR34","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1038\/nature16460","volume":"528","author":"P Aparicio-Domingo","year":"2015","unstructured":"Aparicio-Domingo, P., Romera-Hern\u00e1ndez, M., Karrich, J. J., et al. (2015). The IL-22\u2013OSMR axis regulates the intestinal stem cell niche in inflammation. Nature, 528(7583), 701\u2013705. https:\/\/doi.org\/10.1038\/nature16460","journal-title":"Nature"},{"issue":"11","key":"1954_CR35","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1016\/j.it.2020.10.002","volume":"41","author":"Y Koyama","year":"2020","unstructured":"Koyama, Y., Wang, P., Liang, J., et al. (2020). Extracellular matrix-bound cytokines: New insights into the control of inflammation and tissue repair. Trends in Immunology, 41(11), 1122\u20131136. https:\/\/doi.org\/10.1016\/j.it.2020.10.002","journal-title":"Trends in Immunology"},{"issue":"17","key":"1954_CR36","doi-asserted-by":"publisher","first-page":"e145132","DOI":"10.1172\/jci.insight.145132","volume":"6","author":"CJ Burgess","year":"2021","unstructured":"Burgess, C. J., Lee, J. S., Owen, J. L., et al. (2021). Oncostatin M Blockade ameliorates intestinal inflammation and promotes mucosal healing in murine IBD models. JCI Insight, 6(17), e145132. https:\/\/doi.org\/10.1172\/jci.insight.145132","journal-title":"JCI Insight"},{"key":"1954_CR37","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s10254-003-0003-3","volume":"149","author":"M Tanaka","year":"2003","unstructured":"Tanaka, M., & Miyajima, A. (2003). Oncostatin M, a multifunctional cytokine. Reviews of Physiology Biochemistry and Pharmacology, 149, 39\u201352. https:\/\/doi.org\/10.1007\/s10254-003-0003-3","journal-title":"Reviews of Physiology Biochemistry and Pharmacology"},{"issue":"9","key":"1954_CR38","first-page":"6024","volume":"180","author":"RB Crittenden","year":"2008","unstructured":"Crittenden, R. B., Ju, W., Sano, Y., et al. (2008). STAT3 activation in response to Oncostatin M regulates fibroblast function and contributes to tissue remodeling. Journal of Immunology, 180(9), 6024\u20136031.","journal-title":"Journal of Immunology"},{"issue":"6","key":"1954_CR39","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/S1074-7613(01)00151-0","volume":"14","author":"SM Hurst","year":"2001","unstructured":"Hurst, S. M., Wilkinson, T. S., McLoughlin, R. M., et al. (2001). IL-6 and its soluble receptor orchestrate a Temporal switch in the pattern of leukocyte recruitment seen during acute inflammation. Immunity, 14(6), 705\u2013714.","journal-title":"Immunity"},{"issue":"1","key":"1954_CR40","first-page":"1","volume":"11","author":"Q Chen","year":"2020","unstructured":"Chen, Q., Han, B., Meng, X., et al. (2020). Oncostatin M drives fibrosis in a mouse model of crohn\u2019s disease through STAT3\u2013dependent pathways. Nature Communications, 11(1), 1\u201313.","journal-title":"Nature Communications"},{"issue":"3","key":"1954_CR41","first-page":"91","volume":"26","author":"RJ O\u2019Donoghue","year":"2004","unstructured":"O\u2019Donoghue, R. J., Arthur, J. L., Coyle, A. J., et al. (2004). Expression of Oncostatin M and its receptors in pulmonary inflammation. Cytokine, 26(3), 91\u2013101.","journal-title":"Cytokine"},{"issue":"6","key":"1954_CR42","first-page":"8707","volume":"234","author":"MS Kim","year":"2019","unstructured":"Kim, M. S., Day, C. J., & Morrison, N. A. (2019). Oncostatin M drives tumorigenesis in colon cancer by enhancing stemness and epithelial\u2013mesenchymal transition. Journal of Cellular Physiology, 234(6), 8707\u20138717.","journal-title":"Journal of Cellular Physiology"},{"issue":"14","key":"1954_CR43","doi-asserted-by":"publisher","first-page":"2591","DOI":"10.1158\/0008-5472.CAN-21-4069","volume":"82","author":"A Araujo","year":"2022","unstructured":"Araujo, A., Zhang, M., Yin, F., et al. (2022). Oncostatin M drives cancer-associated fibroblast-mediated immunosuppression and tumor progression in breast cancer. Cancer Research, 82(14), 2591\u20132606. https:\/\/doi.org\/10.1158\/0008-5472.CAN-21-4069","journal-title":"Cancer Research"},{"key":"1954_CR44","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1146\/annurev.immunol.18.1.143","volume":"18","author":"H Yasukawa","year":"2000","unstructured":"Yasukawa, H., Sasaki, A., & Yoshimura, A. (2000). Negative regulation of cytokine signaling pathways. Annual Review of Immunology, 18, 143\u2013164. https:\/\/doi.org\/10.1146\/annurev.immunol.18.1.143","journal-title":"Annual Review of Immunology"},{"issue":"Suppl 2","key":"1954_CR45","doi-asserted-by":"publisher","first-page":"ii111","DOI":"10.1136\/annrheumdis-2012-202576","volume":"72","author":"JJ O\u2019Shea","year":"2013","unstructured":"O\u2019Shea, J. J., Kontzias, A., Yamaoka, K., Tanaka, Y., & Laurence, A. (2013). Janus kinase inhibitors in autoimmune diseases. Annals of the Rheumatic Diseases, 72(Suppl 2), ii111\u2013ii115.","journal-title":"Annals of the Rheumatic Diseases"},{"key":"1954_CR46","doi-asserted-by":"publisher","first-page":"512103","DOI":"10.1155\/2013\/512103","volume":"2013","author":"C. D. Richards","year":"2013","unstructured":"Richards, C. D. (2013). The enigmatic cytokine oncostatin M and roles in disease. ISRN Inflammation, 2013, 512103.","journal-title":"ISRN Inflammation"},{"issue":"3","key":"1954_CR47","first-page":"19","volume":"1","author":"A Muthuraman","year":"2010","unstructured":"Muthuraman, A., & Rishi, P. (2010). Role of SiRNA and antisense oligonucleotides in gene Silencing. International Journal of Pharmaceutical Sciences and Research, 1(3), 19\u201325.","journal-title":"International Journal of Pharmaceutical Sciences and Research"},{"issue":"Suppl 1","key":"1954_CR48","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.1186\/1478-6354-13-S1-S5","volume":"13","author":"PP Tak","year":"2011","unstructured":"Tak, P. P., & Kalden, J. R. (2011). Advances in rheumatology: New targeted therapeutics. Arthritis Research & Therapy, 13(Suppl 1), S5.","journal-title":"Arthritis Research & Therapy"},{"issue":"6","key":"1954_CR49","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1093\/rheumatology\/key339","volume":"58","author":"EH Choy","year":"2019","unstructured":"Choy, E. H. (2019). Clinical significance of Janus kinase inhibitor selectivity. Rheumatology (Oxford), 58(6), 953\u2013962.","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"1954_CR50","first-page":"627","volume":"69","author":"U Billmeier","year":"2020","unstructured":"Billmeier, U., et al. (2020). Shared features of anti-TNF failure in inflammatory bowel disease: A transcriptomic meta-analysis. Gut, 69(3), 627\u2013637.","journal-title":"Gut"},{"issue":"7","key":"1954_CR51","first-page":"2090","volume":"156","author":"WJ Sandborn","year":"2019","unstructured":"Sandborn, W. J., et al. (2019). Safety of anti-TNF combination therapy. Gastroenterology, 156(7), 2090\u20132100.","journal-title":"Gastroenterology"}],"container-title":["Cell Biochemistry and Biophysics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12013-025-01954-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12013-025-01954-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12013-025-01954-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T04:44:17Z","timestamp":1772858657000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12013-025-01954-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,22]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,3]]}},"alternative-id":["1954"],"URL":"https:\/\/doi.org\/10.1007\/s12013-025-01954-5","relation":{},"ISSN":["1559-0283"],"issn-type":[{"value":"1559-0283","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,22]]},"assertion":[{"value":"12 November 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The author declares no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}